<!doctype html>
<html lang="en">

<head>
  <!-- Required meta tags -->
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  <!-- Bootstrap CSS -->
  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/css/bootstrap.min.css" integrity="sha384-9aIt2nRpC12Uk9gS9baDl411NQApFmC26EwAOH8WgZl5MYYxFfc+NcPb1dKGj7Sk" crossorigin="anonymous">

  <!-- Other CSS -->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300;0,400;0,600;0,700;0,800;1,300;1,400;1,600;1,700;1,800&display=swap">
  <link rel="stylesheet" href="bchu.css">
  <link rel="icon" href="images/penn-favicon.png" type="image/x-icon">
  <title>Bone &amp; Joint Infections</title>
</head>


<body>
  <!-- NAVIGATION BAR content goes here -->
  <header class="header-penn">
    <!-- NAVBAR -->
    <nav class="navbar navbar-expand-lg navbar-penn">
      <a class="navbar-brand logo-penn" href="bchu_index.html">
        <img src="images/penn-shield.png" width="30" height="30" class="d-inline-block align-center">
        Penn Med Antimicrobial Stewardship
      </a>
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"><i class="fa fa-bars"></i></span>
      </button>
      <div class="collapse navbar-collapse" id="navbarNav">
        <div class="navbar-nav">
          <a href="bchu_index.html" class="nav-item nav-link ml-4">Home</a>
          <a href="http://www.uphs.upenn.edu/bugdrug/" class="nav-item nav-link ml-4">Microbiology (Bugdrug)</a>
          <a href="#" class="nav-item nav-link ml-4">ID Transition Service (IDTS)</a>
          <a href="#" class="nav-item nav-link ml-4">Education</a>
          <a href="bchu_contact.html" class="nav-item nav-link ml-4">Contact Us</a>
        </div>
      </div>
    </nav>
  </header>

  <div class="container site-content">
    <div class="row">

      <!-- aside for SIDEBAR -->
      <aside class="col-12 col-lg-3">
        <div class="nav-div-penn">
          <nav class="nav flex-column nav-penn">
            <a href="bchu_index.html" class="nav-link">Home</a>
            <a class="nav-link" href="https://ilum.uphs.upenn.edu/">IL&Uacute;M</a>
            <a class="nav-link" href="#">Antibiotic Approval</a>
            <div class="dropdown">
              <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#" role="button" aria-haspopup="true" aria-expanded="false">Treatment Guidelines</a>
              <div class="dropdown-menu" aria-labelledby="dropdownMenuLink">
                <a class="dropdown-item" href="#">Abdominal Infections</a>
                <a class="dropdown-item" href="#">Bone and Joint Infections</a>
                <a class="dropdown-item" href="#">Candida Empiric Treatment</a>
                <a class="dropdown-item" href="#">Central Nervous System Infections</a>
                <a class="dropdown-item" href="#">COVID-19 Infection</a>
                <a class="dropdown-item" href="#">Endocarditis</a>
                <a class="dropdown-item" href="#">Gastroenteritis</a>
                <a class="dropdown-item" href="#">Genitourinary Infections</a>
                <a class="dropdown-item" href="#">Gynecologic and Obstetrics </a>
                <a class="dropdown-item" href="#">Neutropenic Fever</a>
                <a class="dropdown-item" href="#">Respiratory Tract Infections</a>
                <a class="dropdown-item" href="#">Sepsis</a>
                <a class="dropdown-item" href="#">Skin and Soft Tissue Infections</a>
              </div>
            </div>
            <div class="dropdown">
              <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#" role="button" aria-haspopup="true" aria-expanded="false">Prophylaxis Guidelines</a>
              <div class="dropdown-menu" aria-labelledby="dropdownMenuLink">
                <a class="dropdown-item" href="#">Hematologic Malignancy (HUP)</a>
                <a class="dropdown-item" href="#">Solid Organ Transplant (HUP)</a>
                <a class="dropdown-item" href="#">Surgical (CCH/HUP/PPMC/PAH)</a>
                <a class="dropdown-item" href="#">Interventional Radiology (CCH/HUP/PPMC/PAH)</a>
              </div>
            </div>
            <div class="dropdown">
              <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#" role="button" aria-haspopup="true" aria-expanded="false">Antimicrobial Dosing</a>
              <div class="dropdown-menu" aria-labelledby="dropdownMenuLink">
                <div class="dropdown-header">General Agents</div>
                <a class="dropdown-item" href="#">Dosing of Antimicrobial Agents</a>
                <a class="dropdown-item" href="#">Continuous Renal Replacement Therapy (CRRT) Dosing</a>
                <a class="dropdown-item" href="#">Dosing Weights</a>
                <div class="dropdown-divider"></div>
                <div class="dropdown-header">Agents
                  Requiring Therapeutic Monitoring</div>
                <a class="dropdown-item" href="#">Criteria for Pharmacokinetics Consult</a>
                <a class="dropdown-item" href="#">Amikacin</a>
                <a class="dropdown-item" href="#">Gentamicin</a>
                <a class="dropdown-item" href="#">Tobramycin</a>
                <a class="dropdown-item" href="#">Vancomycin</a>
                <a class="dropdown-item" href="#">Aminoglycoside for Cystic Fibrosis</a>
              </div>
            </div>
            <div class="dropdown">
              <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#" role="button" aria-haspopup="true" aria-expanded="false">Antimicrobial Information</a>
              <div class="dropdown-menu" aria-labelledby="dropdownMenuLink">
                <a class="dropdown-item" href="#">Amphotericin B</a>
                <a class="dropdown-item" href="#">Ceftazidime-Avibactam</a>
                <a class="dropdown-item" href="#">Ceftolozane-Tazobactam</a>
                <a class="dropdown-item" href="#">Daptomycin</a>
              </div>
            </div>
            <a class="nav-link" href="#">Antimicrobial Formulary</a>
          </nav>
        </div>
      </aside>

      <!-- article contains the accordion, CSS means 12 mobile, 9 when lg -->
      <article class="col-12 col-lg-9">
        <h1>Bone and Joint Infections</h1>

        <!-- Sample CARD unit -->
        <div class="card mb-4">
          <div class="card-header">Overview</div>
          <div class="card-body">
            <p class="card-text">
              Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see <a href="#">Dosing of Antimicrobial Agents</a>.
            </p>
          </div>
        </div>


        <!-- ACCORDION -->
        <div class="accordion" id="abdominal">
          <div class="card">
            <div class="card-header" id="headingOne">
              <h2 class="mb-0">
                <button class="btn btn-link btn-penn collapsed" type="button" data-toggle="collapse" data-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
                  Osteomyelitis
                </button>
              </h2>
            </div>
            <!--  To show by default, add "show" to the class  -->
            <div id="collapseOne" class="collapse" aria-labelledby="headingOne" data-parent="">
              <div class="card-body">
                <p class="card-text">
                  Includes infections that are secondary to hematogenous spread, those arising from a contiguous focus, including post-traumatic and post-operative infections, and those complicated by the presence of foreign material or implanted hardware.
                </p>
                <p class="card-text">For ideal treatment:</p>
                <ul>
                  <li>Infections should be treated by debridement of infected and necrotic bone.</li>
                  <li>All dead-space should be eliminated by the placement of bone grafts or muscle flaps.</li>
                  <li>Infections require soft-tissue coverage to promote revascularization.</li>
                  <li>Infections require prolonged antibiotics courses directed against the organisms isolated from culture of the bone.</li>
                </ul>
                <p class="card-text">Empiric antibiotic therapy is often NOT required if surgery is planned unless patient has systemic signs of infection (fever, severe sepsis, etc.). Instead, antibiotics should be deferred until after surgery and based on culture results. It is highly desirable to base antibiotic choices on bone or tissue cultures rather than wound or sinus swabs. Obtain cultures from blood (&ge;2 sets) plus bone and deep tissue samples (&ge;3 sets, ideally 5 or 6) at the time of debridement to guide antibiotic treatment.</p>
                <p class="card-text mb-4">The route of antibiotic administration can be parenteral (IV) or oral, provided the oral bioavailability of individual agents is high.</p>

                <h2>Table 1. Empiric Treatment for Osteomyelitis</h2>
                <!-- Sample 3-column TABLE -->
                <div class="table-responsive mb-4">
                  <table class="table table-sm table-penn">
                    <thead class="thead-penn">
                      <tr>
                        <th scope="col">Preferred Therapy</th>
                        <th scope="col">&beta;-Lactam Allergy</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Hematogenous</strong> <br>
                          <i>Streptococcus spp, Methicillin-susceptible/resistant Staphylococcus aureus (MSSA/MRSA)</i></td>
                      </tr>
                      <tr>
                        <td colspan="2">Vancomycin IV (<a href="#">dosing</a>)</td>
                      </tr>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Contiguous Post-Operative</strong> <br>
                          <i>MSSA/MRSA, Coagulase-negative Staphylococcus, Enterobacteriaceae, Pseudomonas aeruginosa</i></td>
                      </tr>
                      <tr>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Cefepime 1gm IV Q8H</td>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Levofloxacin 750 mg IV/PO daily</td>
                      </tr>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Contiguous Post-Traumatic</strong> <br>
                          <i>MSSA/MRSA, Coagulase-negative Staphylococcus, Enterobacteriaceae, Pseudomonas aeruginosa, Anaerobes</i></td>
                      </tr>
                      <tr>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Piperacillin/tazobactam 4.5 gm IV Q8H</td>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg IV/PO Q12H</td>
                      </tr>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Diabetic Foot</strong> <br>
                          <i>Streptococcus spp, MSSA/MRSA, Enterobacteriaceae, P. aeruginosa, Anaerobes</i></td>
                      </tr>
                      <tr>
                        <td>Option 1: Vancomycin IV (<a href="#">dosing</a>) AND Piperacillin/tazobactam 4.5 gm IV Q8H <br><br> Option 2: Vancomycin IV (<a href="#">dosing link</a>) AND Cefepime 1gm IV Q8H AND Metronidazole 500 mg IV/PO Q12H</td>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg IV/PO Q12H</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <h2>Table 2. Duration of Treatment for Osteomyelitis</h2>
                <div class="table-responsive">
                  <table class="table table-sm table-penn">
                    <thead class="thead-penn">
                      <tr>
                        <th scope="col">Clinical Setting</th>
                        <th scope="col">Duration</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <th scope="row">Osteitis<br><i>Infection extending to the surface of the bone but without bone necrosis or the presence of bone in an infected operative field</i></th>
                        <td><b>4 weeks</b></td>
                      </tr>
                      <tr>
                        <th scope="row"><strong>Osteomyelitis without Hardware</strong> <br>
                          <i>An infection involving bone without presence of hardware</i></th>
                        <td>
                          <p><b>6-8 weeks</b></p>
                          <p>Comment: Ideally requires debridement for greatest chance of cure</p>
                        </td>
                      </tr>
                      <tr>
                        <th scope="row"><strong>Osteomyelitis with Hardware</strong> <br>
                          <i>An infection involving bone in the presence of hardware</i></th>
                        <td>
                          <p><b>If original hardware removed: 6-8 weeks</b></p>
                          <p><b>If original hardware retained: 6-8 weeks of parenteral therapy</b></p>
                          <p>Consult Infectious Diseases for consideration of suppressive therapy.</p>
                          <p>Infected hardware complicates management of osteomyelitis. Debridement without hardware removal is associated with lower cure rates. However, fracture instability and non-union are a consequence of inadequate fixation, and the application of external fixation can be challenging or not at all possible.</p>
                          <p>When possible infected hardware should be removed in staged approach (hardware removal, interval antibiotic treatment followed by fixation with new hardware or bone grafting).</p>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                </div>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingTwo">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
                  Septic Arthritis
                </button>
              </h2>
            </div>
            <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="">
              <div class="card-body">
                <p class="card-text">In most cases, infection arises secondary to hematogenous spread to the joint, although it also can arise from a bite or from other direct traumatic inoculation and rarely, from direct inoculation of bacteria during joint procedures.</p>
                <p class="card-text">Treatment requires adequate drainage of purulent joint fluid and appropriate antimicrobial therapy.</p>
                <p class="card-text">Obtain blood, joint fluid, and other appropriate cultures (e.g. throat, vaginal, urethral, rectal if <i>Neisseria gonorrhoeae</i> is suspected) before starting empiric antimicrobial therapy.</p>
                <!-- Sample 3-column TABLE -->
                <div class="table-responsive">
                  <table class="table table-sm table-penn">
                    <thead class="thead-penn">
                      <tr>
                        <th scope="col">Preferred Therapy</th>
                        <th scope="col">&beta;-Lactam Allergy</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>No risk for sexually-transmitted infection</strong> <br>
                          <i>Streptococcus spp, Staphylococcus aureus, Enterobacteriaceae</i></td>
                      </tr>
                      <tr>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Ceftriaxone 1gm IV daily</td>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Levofloxacin 750 mg IV/PO daily</td>
                      </tr>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Risk for sexually-transmitted infection</strong> <br>
                          <i>Streptococcus spp, Staphylococcus aureus, Neisseria gonorrhoeae, Enterobacteriaceae</i></td>
                      </tr>
                      <tr>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Ceftriaxone 1gm IV daily AND Doxycycline 100 mg PO Q12H</td>
                        <td>Consult Infectious Diseases</td>
                      </tr>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Post-procedure or post-injection</strong> <br>
                          <i>Streptococcus spp, Staphylococcus aureus, Enterobacteriaceae, Anaerobes</i></td>
                      </tr>
                      <tr>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Cefepime 1gm IV Q8H AND Metronidazole 500 mg PO Q12H</td>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Levofloxacin 750 mg PO daily AND Metronidazole 500 mg PO Q12H</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingThree">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
                  Prosthetic Joint Infections
                </button>
              </h2>
            </div>
            <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="">
              <div class="card-body">
                <p class="card-text">Prosthetic joint infections (PJI) may occur in 1% of patients undergoing total hip and total knee arthroplasty, and less commonly in patients undergoing shoulder arthroplasty. Once a patient has had a PJI, their risk of subsequent PJI rises.</p>
                <p class="card-text">Early-onset PJI (infection within 90 days of implantation) is often caused by peri-operative contamination or seeding.</p>
                <p class="card-text">Late-onset PJI may have several causes including non-healing wound, joint trauma, or intercurrent bacteremia with hematogenous dissemination and seeding of the joint.</p>
                <p class="card-text">Optimal management of PJI is a two-step exchange as it provides the best chance for cure of infection. However, in some subpopulations of patients a two-step exchange is not feasible.</p>
                <p class="card-text mb-4">The decision to use oral antibiotic therapy for a short period after joint re-implantation, or for chronic suppression is not a standard recommendation, should be considered on a case-by-csae basis, and should only be considered in the setting of Infectious Diseases consultation.</p>
                <h2>Table 1. Empiric Treatment for Prosthetic Joint Infections</h2>
                <!-- Sample 3-column TABLE -->
                <div class="table-responsive mb-4">
                  <table class="table table-sm table-penn">
                    <thead class="thead-penn">
                      <tr>
                        <th scope="col">Preferred Therapy</th>
                        <th scope="col">&beta;-Lactam Allergy</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr class="tr-penn">
                        <td colspan="2"><strong>Prosthetic Hardware-Associated</strong> <br>
                          <i>Streptococcus spp, MSSA/MRSA, Coagulase-negative Staphylococcus, Enterobacteriaceae, P. aeruginosa</i></td>
                      </tr>
                      <tr>
                        <td>Vancomycin IV (<a href="#">dosing</a>) AND Cefazolin 2g IV Q8H</td>
                        <td>Vancomycin IV (<a href="#">dosing</a>)</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <h2>Table 2. Duration of Treatment for Prosthetic Joint Infections</h2>
                <div class="table-responsive mb-4">
                  <table class="table table-sm table-penn">
                    <thead class="thead-penn">
                      <tr>
                        <th scope="col">Typical Pathogens</th>
                        <th scope="col">Preferred Therapy</th>
                        <th scope="col">&beta;-Lactam Allergy</th>
                        <th scope="col">Duration</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr class="tr-penn">
                        <td colspan="4"><strong>PJI with or without planned staged reimplantation, <br> PJI following 1 stage exchange<sup>1</sup></strong></td>
                      </tr>
                      <tr>
                        <th scope="row">MSSA</th>
                        <td>Cefazolin 2g IV q8h OR Nafcillin 2g IV Q4H +/- Rifampin 300mg PO Q12H<sup>2</sup></td>
                        <td>Vancomycin IV (<a href="#">dosing</a>) OR Daptomycin 6mg/kg IV daily OR Linezolid 600mg PO/IV Q12H +/- Rifampin 300mg PO Q12H<sup>2</sup></td>
                        <td rowspan="3">6 weeks</td>
                      </tr>
                      <tr>
                        <th scope="row">MRSA</th>
                        <td colspan="2">Vancomycin IV (<a href="#">dosing</a>) OR Daptomycin 6mg/kg IV daily OR Linezolid 600mg PO/IV Q12H</td>
                      </tr>
                      <tr>
                        <th scope="row">Others</th>
                        <td colspan="2">Pathogen directed therapy intravenous or highly bioavailable oral antimicrobial therapy</td>
                      </tr>
                      <tr class="tr-penn">
                        <td colspan="4"><strong>PJI with subsequent amputation</strong></td>
                      </tr>
                      <tr>
                        <th scope="row">All</th>
                        <td colspan="2">Pathogen directed therapy intravenous or highly bioavailable oral antimicrobial therapy</td>
                        <td>See note<sup>3</sup></td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <div class="table-subtext">
                  <p><sup>1</sup>Consultation with Infectious Diseases TODO recommended appropriate antimicrobial agent and duration for suppressive therapy</p>
                  <p><sup>2</sup>Rifampin should only be recommended in consultation with ID consult prior to prescribing due to risk of adverse drug events and drug-drug interactions.</p>
                  <p><sup>3</sup>Continue until 24-48 hours post amputation if all infected bone removed. If residual bone or soft tissue infection, continue pathogen directed antimicrobials for 4-6 weeks</p>
                </div>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingFour">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
                  References
                </button>
              </h2>
            </div>
            <div id="collapseFour" class="collapse" aria-labelledby="headingFour" data-parent="">
              <div class="card-body">
                <ul>
                  <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23223583">Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: e1-e25.</a></li>
                  <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/22619242">Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: 1679-84.</a></li>
                </ul>
              </div>
            </div>
          </div>
        </div>
        <br>
        <p>Last updated April 11, 2018</p>
      </article>
    </div>



  </div>

  <!-- FOOTER -->
  <footer class="footer-penn">
    Penn Medicine, Philadelphia, PA 800-789-PENN © 2020, The Trustees of the University of Pennsylvania
  </footer>

  <!-- Optional JavaScript -->
  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.0/dist/umd/popper.min.js" integrity="sha384-Q6E9RHvbIyZFJoft+2mJbHaEWldlvI9IOYy5n3zV9zzTtmI3UksdQRVvoxMfooAo" crossorigin="anonymous"></script>
  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/js/bootstrap.min.js" integrity="sha384-OgVRvuATP1z7JjHLkuOU7Xw704+h835Lr+6QL9UvYjZE3Ipu6Tp75j7Bh/kR0JKI" crossorigin="anonymous"></script>
  <!-- Font Awesome icon script -->
  <script src="scripts/accordion-collapse.js"></script>
</body></html>